Cargando…

BRAF-mutant hematopoietic malignancies

Detalles Bibliográficos
Autores principales:	Abdel-Wahab, Omar, Park, Christopher Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Editorial Materials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226659/ https://www.ncbi.nlm.nih.gov/pubmed/25478626

Ejemplares similares

Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim–Chester disease patients following BRAF inhibitor monotherapy
por: Mazor, Roei D, et al.
Publicado: (2020)

CDK6 and p16(INK4A) in lymphoid malignancies
por: Kollmann, Karoline, et al.
Publicado: (2013)

Combination drug development in BRAF mutant colorectal cancer
por: Lam, Michael, et al.
Publicado: (2018)

Targeting BRAF-mutant tumours with TGFBR1 inhibitors
por: Spender, Lindsay C, et al.
Publicado: (2017)

Highlight report: Protection of cholestatic livers by shunting of bile from canaliculi to sinusoids
por: Abbass, Tahany, et al.
Publicado: (2018)

Gebel-criteria for risk assessment in nanotoxicology
por: Hammad, Seddik, et al.
Publicado: (2014)

Perspectives of tissues in silico
por: Hammad, Seddik, et al.
Publicado: (2015)

C. elegans ATG-5 mutants associated with ataxia
por: Yugeta, Azusa, et al.
Publicado: (2023)

Lessons from clinical trials on triple combination of immune checkpoint inhibitors and BRAF/MEK inhibitors in BRAF-mutant melanoma
por: Maeda, Takuya, et al.
Publicado: (2023)

Anticancer compounds from plants
por: Park, Sang Un
Publicado: (2012)

Recent studies on rosmarinic acid and its biological and pharmacological activities
por: Al-Dhabi, Naif Abdullah, et al.
Publicado: (2014)

Recent studies on flavonoids and their antioxidant activities
por: Chae, Soo Cheon, et al.
Publicado: (2013)

Neuroprotective effects of medicinal plants
por: Uddin, Romij, et al.
Publicado: (2013)

Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogramed primary prostate cancer cells.
por: Pollock, Claire B, et al.
Publicado: (2014)

Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

JKK-1(3E), a JKK-1 mutant with predicted phosphomimetic amino acid substitutions
por: Busack, Inka, et al.
Publicado: (2023)

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016)

Medical debulking with BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma
por: Di Stefano, Anna Luisa, et al.
Publicado: (2020)

Invasive leader cells: metastatic oncotarget
por: Cheung, Kevin J., et al.
Publicado: (2014)

IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014)

PTSD in the military: special considerations for understanding prevalence, pathophysiology and treatment following deployment
por: Yehuda, Rachel, et al.
Publicado: (2014)

A long lasting puzzle for −7/7q− syndrome
por: Honda, Hiroaki, et al.
Publicado: (2014)

Targeting leukemia stem cells: in vitro veritas?
por: Bond, Heather M., et al.
Publicado: (2014)

Dopamine signaling: target in glioblastoma
por: Bartek, Jiri, et al.
Publicado: (2014)

Select a suitable treatment strategy for Crohn's disease: step-up or top-down
por: Chen, Qian-Qian, et al.
Publicado: (2014)

Concepts of predictive toxicology
por: Reif, Raymond
Publicado: (2014)

In silico protein modeling: possibilities and limitations
por: Gupta, Chhedi Lal, et al.
Publicado: (2014)

Human non-parenchymal liver cells for co-cultivation systems
por: Ghallab, Ahmed
Publicado: (2014)

Biomarker: the universe of chemically induced gene expression alterations in human hepatocyte
por: Hammad, Seddik, et al.
Publicado: (2014)

Integrated spatiotemporal-metabolic modelling bridges the gap between metabolism on the cellular level and organ function
por: Widera, Agata
Publicado: (2014)

Highlight report: Validation of prognostic genes in lung cancer
por: Marchan, Rosemarie
Publicado: (2014)

Transcriptome based differentiation of harmless, teratogenetic and cytotoxic concentration ranges of valproic acid
por: Stöber, Regina
Publicado: (2014)

The post GWAS era: strategies to identify gene-gene and gene-environment interactions in urinary bladder cancer
por: Selinski, Silvia
Publicado: (2014)

Phytochemicals for treatment of diabetes
por: Firdous, S. M.
Publicado: (2014)

Cancer research: from prognostic genes to therapeutic targets
por: Marchan, Rosemarie
Publicado: (2014)

The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI)
por: Ghallab, Ahmed
Publicado: (2014)

Data on characterization and performance of aspartic acid functionalized graphene oxide-polysulfone mixed matrix membranes
por: Abdalla, Omnya, et al.
Publicado: (2020)

In vivo selection of tumor-specific antibodies
por: Sánchez-Martín, David, et al.
Publicado: (2013)

Estrogen response in luminal breast cancer
por: Rangel, Leticia B. A., et al.
Publicado: (2013)

IκBα beyond the NF-kB dogma
por: Mulero, Maria Carmen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c7efa86d98p0v7akj0m72dk5c7